← Eichor
Condition: Red Blood Cell Transfusions Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Red Blood Cell Transfusions

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Effects of Donor-recipient Sex-matched Blood Transfusion on Patient Outcomes
Phase 4 · 8 location(s) · Michelle Zeller · NCT06840756The Effect of Combined Iron Protocols on Perioperative Allogeneic Transfusion
NA · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT06012760RH Genotype Matched RBC Transfusions
Phase 1/Phase 2 · 1 location(s) · Children's Hospital of Philadelphia · NCT04156893Blood Storage Related Mortality and Adverse Effects in Trauma Patients
Phase N/A · 1 location(s) · Kocaeli City Hospital · NCT07341139Variation of Echocardiographic Parameters After Red Blood Cell Transfusion in Emergency Department Anemic Patients
NA · 1 location(s) · Centre Hospitalier Universitaire de Nīmes · NCT06060639Comparison of Hemanext ONE® System and Conventional Red Blood Cell Transfusion
NA · 1 location(s) · Hemanext · NCT06685848Hemoglobin Levels for Blood Transfusions During and After Surgery
NA · 1 location(s) · Ottawa Hospital Research Institute · NCT06718439Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia
Phase 2 · 26 location(s) · Celgene · NCT04143724Evaluating the Effects of Hemoglobin Threshold-specific Packed Red Blood Cell Transfusions on Quality of Life and Functi
NA · 1 location(s) · University of Washington · NCT06710418A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myel
Phase 3 · 156 location(s) · Takeda · NCT07422480Modeling Blood Management and Hemolytic Risk in Pediatric Heart Surgery
Phase N/A · 1 location(s) · Boston Children's Hospital · NCT06721455Study to Understand the Genetic Risk of Developing an Immune Response After Blood Transfusions Among Individuals With Si
Phase N/A · 1 location(s) · National Human Genome Research Institute (NHGRI) · NCT06944067Individualized ANH for Non-cardiac Surgery
NA · 1 location(s) · West China Hospital · NCT06399536The Effect of Retrograde Autologous Priming on Transfusion Requirements After Cardiac Surgery
NA · 4 location(s) · Population Health Research Institute · NCT06230198Restrictive Versus Liberal Thresholds for RBC Transfusion in ECMO
NA · 12 location(s) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC · NCT06560164S-Nitrosylation (SNO) Therapy During Autologous Blood Transfusion
Phase 1 · 1 location(s) · James Reynolds · NCT03999229grouP O wholE blooD : storagE leSion impacT And infLammation
NA · 1 location(s) · Etablissement Français du Sang · NCT06809010WithHolding Enteral Feeds Around Blood Transfusion (International)
NA · 40 location(s) · IWK Health Centre · NCT05213806Transfusion in Lower Risk MDS Patients: Predictors of Adequacy of Transfusion and Quality of Life in Lower Risk MDS
Phase N/A · 1 location(s) · Fundación para la Investigación Biosanitaria del Principado · NCT06614595Trauma Resuscitation With Low-Titer Group O Whole Blood or Products
Phase 3 · 13 location(s) · University of Alabama at Birmingham · NCT05638581Efficacy and Safety of Luspatercept for the Treatment of Anemia Due to MDS With del5q, Refractory/Resistant/Intolerant t
Phase 2 · 23 location(s) · Associazione Qol-one · NCT05924100Blood Warming in Preterm Infants to Decrease Hypothermia
NA · 1 location(s) · University of South Carolina · NCT05170633Red Blood Cell Transfusion in ECMO - A Feasibility Trial
NA · 2 location(s) · Australian and New Zealand Intensive Care Research Centre · NCT05814094Biomarkers in Patients With Anemia-Induced Thrombocytopenic Bleeding
NA · 1 location(s) · Donald Arnold · NCT06947044Transfusion-Related Changes in Oxidative Stress Biomarkers in Neonates
Phase N/A · 1 location(s) · Medical University of Graz · NCT07672275Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT
Phase 2 · 1 location(s) · Paul Szabolcs · NCT01962415Comparative Analysis of Biotinylated, Irradiated and 51-Chromium Radiolabeled Red Blood Cells for Analysis of Recovery a
Phase 1 · 2 location(s) · Jose Cancelas · NCT07446647
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.